Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Research Fellow

Molecular Biology · Japan · 2022-04-25

Processing Time
63 days
Decision Date
2022-04-25
Location
Maryland
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing liquid-based, non-invasive biomarker identification and cancer treatment strategies to advance innovations in the care of prostate cancer patients. Her work focuses on the development of novel detection and treatment protocols for metastatic castration-resistant prostate cancer (mCRPC) to improve patient outcomes and quality of life.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses prostate cancer, the second leading cause of cancer death in U.S. men, affecting 250,000 new patients annually.

2 Well-positioned to Advance the Endeavor Met

The petitioner has over 12 years of experience, a Ph.D. in urology, and a record of 16 publications with 190 citations.

3 Waiver Benefit Met

The research provides immediate applicability in promoting national health outcomes and reducing healthcare expenses, justifying the waiver of labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in urology and over 12 years of experience in the field. Evidence included 16 peer-reviewed journal articles (5 first-authored) and 1 book chapter, which accumulated 190 citations. Additionally, she completed 9 peer reviews, demonstrating her standing in the scientific community and satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Judging Experience
Original Contributions

Similar Cases

Researcher

Healthcare · Denmark

WeGreened EB-2 (NIW) approved
California 27 days 2023-02-08
The petitioner proposes to develop new diagnostic and treatment selection tools to optimize the management of cancer, specifically focusing on technologies like prostate segmentation for biopsies. This work aims to improve accuracy in procedures performed by physicians to reduce mortality rates and enhance personalized treatment outcomes.
View Case

Others

Healthcare · Ireland

WeGreened EB-2 (NIW) approved
19 days 2025-05-05
The petitioner proposes to apply patient-centered analytics and AI-based modeling to improve decision-making and personalize care for prostate cancer. The work focuses on developing predictive models for prostatectomy outcomes and robotic surgical techniques to stratify risk and tailor clinical interventions. This endeavor aims to reduce patient morbidity and mortality through earlier diagnoses and better-informed surgical decisions.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 60 days 2025-01-18
The petitioner proposes to identify critical mechanisms of antiandrogen drug resistance to develop novel targeted therapies for advanced prostate cancer. This work involves validating novel compounds and uncovering therapeutic targets to improve clinical outcomes for oncology patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Japan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-25.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 63 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Japan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist